Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling.
Yun ChangFeng LanYongshuai ZhangShuhong MaPublished in: Stem cell reviews and reports (2024)
The CRISPR system, as an effective genome editing technology, has been extensively utilized for the construction of disease models in human pluripotent stem cells. Establishment of a gene mutant or knockout stem cell line typically relies on Cas nuclease-generated double-stranded DNA breaks and exogenous templates, which can produce uncontrollable editing byproducts and toxicity. The recently developed adenine base editors (ABE) have greatly facilitated related research by introducing A/T > G/C mutations in the coding regions or splitting sites (AG-GT) of genes, enabling mutant gene knock-in or knock-out without introducing DNA breaks. In this study, we edit the AG bases in exons anterior to achieve gene knockout via the ABE8e-SpRY, which recognizes most expanded protospacer adjacent motif to target the genome. Except for gene-knockout, ABE8e-SpRY can also efficiently establish disease-related A/T-to-G/C variation cell lines by targeting coding sequences. The method we generated is simple and time-saving, and it only takes two weeks to obtain the desired cell line. This protocol provides operating instructions step-by-step for constructing knockout and point mutation cell lines.
Keyphrases
- crispr cas
- genome editing
- pluripotent stem cells
- genome wide
- genome wide identification
- copy number
- endothelial cells
- dna methylation
- wild type
- randomized controlled trial
- drinking water
- circulating tumor
- quantum dots
- cell free
- gene expression
- oxidative stress
- multidrug resistant
- transcription factor
- gestational age
- preterm birth